Braun Stacey Associates Inc Halozyme Therapeutics, Inc. Transaction History

Braun Stacey Associates Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 08, 2023	SELL	$32.86 - $55.7 $11 Million - $18.6 Million	-334,021 Reduced 95.16%	16,998 $649,000
Q4 2022 Feb 07, 2023	BUY	$40.06 - $59.44 $3.76 Million - $5.58 Million	93,897 Added 36.52%	351,019 $20 Million
Q3 2022 Nov 08, 2022	BUY	$38.53 - $51.78 $9.91 Million - $13.3 Million	257,122 New	257,122 $10.2 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Braun Stacey Associates Inc with notifications on news.